Gross Profit On Sales تغییر دادن تاریخ
Acadia Pharmaceuticals USD 213.15M 16.07M 2023-12
Agios Pharmaceuticals USD 6.52M 249K 2023-12
Alnylam Pharmaceuticals USD 353.86M 312.36M 2023-12
AstraZeneca USD 9.43B 15M 2023-09
Bluebird Bio USD 1.44M 4.11M 2023-09
Bristol-Myers Squibb USD 8.77B 294M 2023-12
Eli Lilly USD 7.57B 73.1M 2023-12
Esperion Therapeutics USD 20.59M 1.59M 2023-09
Halozyme Therapeutics USD 177.74M 16.53M 2023-12
Heron Therapeutics USD 13.23M 1.62M 2023-09
Insmed USD 65.25M 2.88M 2023-12
J&J USD 14.6B 374M 2023-12
Lexicon Pharmaceuticals USD 155K 154K 2023-09
Ligand Pharmaceuticals USD 26.46M 2.92M 2023-12
Merck USD 11.29B 441M 2023-12
Moderna USD 1.88B 2.29B 2023-12
Pfizer USD 7.58B 3.26B 2023-12
PTC Therapeutics USD 277.94M 90.85M 2023-12
Takeda JPY 699.51B 38B 2023-09
Teva Pharmaceutical Industries USD 1.9B 20M 2023-09
Ultragenyx Pharmaceutical USD 115.34M 28.28M 2023-12
Vanda Pharmaceuticals USD 42.56M 15.17M 2023-06
Veracyte USD 68.82M 6.32M 2023-12



Vanda Pharmaceuticals سود ناخالص در فروش - ارزش های فعلی، داده های تاریخی، پیش بینی، آمار، نمودار و تقویم اقتصادی - Mar 2024.